Atherosclerosis in Vietnamese patients with systemic sclerosis and its relationship to disease and traditional risk

Thuy Nguyen Thi Phuong1, Trang Dao Thi2, Ingrid E Lundberg3

  • 1Rheumatology Department, Bach Mai Hospital.

Insights

Vietnamese patients with Systemic Sclerosis (SSc) have a higher risk of cardiovascular disease (CVD) and subclinical atherosclerosis. Risk factors include traditional and SSc-related elements, highlighting the need for early detection and management.

Area of Science:

  • Rheumatology
  • Cardiology
  • Vascular Biology

Background:

  • Systemic Sclerosis (SSc) is a chronic autoimmune disease associated with increased cardiovascular morbidity.
  • Subclinical atherosclerosis, a precursor to clinical cardiovascular disease (CVD), is a significant concern in SSc patients.
  • Understanding the prevalence and risk factors for atherosclerosis in SSc is crucial for patient management.

Purpose of the Study:

  • To determine the frequency of clinical and subclinical atherosclerosis in Vietnamese patients with SSc.
  • To identify risk factors associated with subclinical atherosclerosis in this population.

Main Methods:

  • A case-control study involving 46 SSc patients and 42 healthy controls of Kinh ethnicity.
  • Assessment of clinical data, cardiovascular disease events, serum lipid profiles, and high-sensitivity C-reactive protein (hs-CRP).
  • Carotid Doppler ultrasonography to measure intima-media thickness (IMT) and detect carotid plaques.

Main Results:

  • SSc patients experienced significantly more CVD events than controls (21.7% vs 0%).
  • Elevated total cholesterol and low high-density lipoprotein cholesterol levels were observed in SSc patients.
  • Common carotid artery IMT was significantly higher in SSc patients, with positive correlations to age, disease duration, and lipid levels.
  • Carotid atherosclerotic plaques were present in 28.3% of SSc patients, absent in controls.

Conclusions:

  • Vietnamese SSc patients exhibit an increased risk of CVD events and subclinical atherosclerosis.
  • Both traditional and SSc-specific risk factors contribute to atherosclerosis in this cohort.
  • Findings underscore the importance of cardiovascular risk assessment in SSc management.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
36
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
73
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
51
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
31